Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent
1994-01-06
1997-02-18
Cintins, Marianne M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
514169, 552544, A61K 3156, C07J 900
Patent
active
056042167
ABSTRACT:
Pharmaceutical and nutritional compositions are disclosed containing, in association with a suitable diluent or carrier, at least 10% by weight of a cholesterol fatty acid ester where the fatty acid is gamma-linolenic acid, dihomo-gamma-linolenic acid, adrenic acid, the 22:5 n-6 acid, stearidonic acid, the 20:4 n-3 acid, eicosapentaenoic acid, docosahexaenoic acid, the 22:5 n-3 acid or columbinic acid. Novel cholesterol columbinic acid esters are described.
REFERENCES:
Rovesti; "Impieghi Cosmetologici Degli Arachidonati Di Colesterile E Di Ascorbile"; Riv. Ital. Essemze-Profumi, Piante Offic., Aromi-Saponi, Cosmet-Aerosol.; vol. 50, No. 8, 1968, pp. 432-434.
Abdulla et al.; "Differential Resorption Rates of Subcutaneous Implants of [.sup.3 H]Cholesterol, Varios [.sup.3 H]Cholesterol esters and [.sup.3 H]Cholesterol-[1-.sup.14 C]Linolenate; Journal of Atherosclerosis Research"; vol. 9, No. 1, 1969; pp. 81-85.
Sklart et al.; "Induced Circular Dichroism of Incorporated Fluorescent Cholesteryl Esters and Polar Lipids as a Probe of Human Serum Low Density Lipoprotein Structure and Melting"; J. Biol. Chem.; vol. 256, No. 9, 1981; pp. 4286-4292.
Rossner et al.; "Fat Emulsions with Added Free Cholesterol or Fatty Acid Cholesteryl Esters"; Nutr. Metab.; vol. 21, No. 6, 1977; pp. 349-357.
Pownall et al.; "Effect of Saturated and Polyunsaturated Fat Diets on the Composition and Structure of Human Low Density Lipoproteins"; Atherosclerosis; vol. 36, No. 3, 1980; pp. 299-314.
Subbaiah et al.; "Incorporation of Dietary N-3 Fatty Acids Into Molecular Species of Phosphatidyl Choline and Cholesteryl Ester in Normal Human Plasma .sup.1-3 "; Am. J. Clin. Nutr.; vol. 58, 1993; pp. 360-368.
X. Fang et al. "High Performance liquid chromatography . . . " Jour. of Liquid Chromatography, 14(3), 1991, pp. 589-598.
E. Hoving et al. "Separation of cholesterol esters . . . " Jour. of Chromatography, 565 (1991), pp. 103-110.
J. H. Shand et al. "The esterification of cholesterol in the yolk . . . " Lipids, 28(7), 1993, pp. 621-625.
Intl Journal of Clinical Pharmacology Therapy & Toxicology, 1986, 24(12), pp. 668-670.
European Drug Directory, Ed. 2, Paris, SEMP Editions, 1992, p. 1249.
Kagawa et al, Chemical Abstracts, vol. 102, No. 23, abstract #203048u, 1985, p. 523.
Glick et al, Chemical Abstracts, vol. 107, No. 3, abstract #21426m, 1987, p. 438.
Cintins Marianne M.
Jarvis William R. A.
Scotia Holdings PLC
LandOfFree
Compositions containing esters of unsaturated fatty acids does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions containing esters of unsaturated fatty acids, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions containing esters of unsaturated fatty acids will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1602596